<p>Preface xvii</p> <p><b>Part 1 Nanomaterials, Fabrication and Biomedical Applications</b></p> <p><b>1 Electrospinning Materials for Skin Tissue Engineering 3<br /> </b><i>Beste Kinikoglu</i></p> <p>1.1 Skin Tissue Engineering Scaffolds 4</p> <p>1.2 Conclusions 14</p> <p>References 15</p> <p><b>2 Electrospinning: A Versatile Technique to Synthesize Drug Delivery Systems 21<br /> </b><i>Xueping Zhang, Dong Liu and Tianyan You</i></p> <p>2.1 Introduction 21</p> <p>2.2 The Types of Delivered Drugs 22</p> <p>2.3 Polymers Used in Electrospinning 29</p> <p>2.4 The Development of Electrospinning Process for Drug Delivery 36</p> <p>2.5 Conclusions 41</p> <p>Acknowledgment 42</p> <p>References 42</p> <p><b>3 Electrospray Jet Emission: An Alternative Interpretation Invoking Dielectrophoretic Forces 51<br /> </b><i>Francesco Aliotta, Oleg Gerasymov and Pietro Calandra</i></p> <p>3.1 Introduction 52</p> <p>3.2 Electrospray: How It Works? 54</p> <p>3.3 Historical Background 63</p> <p>3.4 How the Current (and Wrong) Description of the Electrospray Process Has Been Generated? 65</p> <p>3.5 What Is Wrong in the Current Description? 68</p> <p>3.6 Some Results Shedding More Light 70</p> <p>3.7 Discriminating between Electrophoretic and Dielectrophoretic Forces 72</p> <p>3.8 Some Theoretical Aspects of Dielectrophoresis 76</p> <p>3.9 Conclusions 83</p> <p>References 86</p> <p><b>4 Advanced Silver and Oxide Hybrids of Catalysts During Formaldehyde Production 91<br /> </b><i>Anita Kovač Kralj</i></p> <p>4.1 Introduction 92</p> <p>4.2 The Catalysis 93</p> <p>4.3 Case Study 95</p> <p>4.4 Limited Hybrid Catalyst Method for Formaldehyde Production 97</p> <p>4.5 Conclusion 104</p> <p>4.6 Nomenclatures 105</p> <p>References 105</p> <p><b>5 Physico-chemical Characterization and Basic Research Principles of Advanced Drug Delivery Nanosystems 107<br /> </b><i>Natassa Pippa, Stergios Pispas and Costas Demetzos</i></p> <p>5.1 Introduction 108</p> <p>5.2 Basic Research Principles and Techniques for the Physicochemical Characterization of Advanced Drug Delivery Nanosystems 108</p> <p>5.3 Conclusions 122</p> <p>References 122</p> <p><b>6 Nanoporous Alumina as an Intelligent Nanomaterial for Biomedical Applications 127<br /> </b><i>Moom Sinn Aw and Dusan Losic</i></p> <p>6.1 Introduction 127</p> <p>6.2 Nanoporous Anodized Alumina as a Drug Nano-carrier 129</p> <p>6.3 Biocompatibility of NAA and NNAA Materials 138</p> <p>6.4 NAA for Diabetic and Pancreatic Applications 143</p> <p>6.5 NAA Applications in Orthopedics 144</p> <p>6.6 NAA Applications for Heart, Coronary, and Vasculature Treatment 148</p> <p>6.7 NAA in Dentistry 150</p> <p>6.8 Conclusions and Future Prospects 152</p> <p>Acknowledgment 153</p> <p>References 154</p> <p><b>7 Nanomaterials: Structural Peculiarities, Biological Effects, and Some Aspects of Applications 161<br /> </b><i>N.F. Starodub, M.V. Taran, A.M. Katsev, C. Bisio and M. Guidotti</i></p> <p>7.1 Introduction 162</p> <p>7.2 Physicochemical Properties Determining the Bioavailability and Toxicity of NPS 164</p> <p>7.3 Current Nanoecotoxicological Knowledge 168</p> <p>7.4 Modern Direction of the Application of Nanocomposites as Basis for Detoxication Process 187</p> <p>7.5 Conclusions 189</p> <p>Acknowledgments 190</p> <p>References 190</p> <p><b>8 Biomedical Applications of Intelligent Nanomaterials 199<br /> </b><i>M. D. Fahmy, H. E. Jazayeri, M. Razavi, M. Hashemi, M. Omidi, M. Farahani, E. Salahinejad, A. Yadegari, S. Pitcher and Lobat Tayebi</i></p> <p>8.1 Introduction 200</p> <p>8.2 Polymeric Nanoparticles 202</p> <p>8.3 Lipid-based Nanoparticles 206</p> <p>8.4 Carbon Nanostructures 213</p> <p>8.5 Nanostructured Metals 219</p> <p>8.6 Hybrid Nanostructures 223</p> <p>8.7 Concluding Remarks 228</p> <p>References 229</p> <p><b>Part 2 Nanomaterials for Energy, Electronics, and Biosensing</b></p> <p><b>9 Phase Change Materials as Smart Nanomaterials for Thermal Energy Storage in Buildings 249<br /> </b><i>M. Kheradmand, M. Abdollahzadeh, M. Azenha and J.L.B. de Aguiar</i></p> <p>9.1 Introduction 250</p> <p>9.2 Phase Change Materials: Definition, Principle of Operation, and Classifications 252</p> <p>9.3 PCM-enhanced Cement-based Materials 254</p> <p>9.4 Hybrid PCM for Thermal Storage 255</p> <p>9.5 Numerical Simulations 267</p> <p>9.6 Thermal Modeling of Phase Change 269</p> <p>9.7 Nanoparticle-enhanced Phase Change Material 280</p> <p>9.8 Conclusions (General Remarks) 288</p> <p>References 289</p> <p><b>10 Nanofluids with Enhanced Heat Transfer Properties for Thermal Energy Storage 295<br /> </b><i>Manila Chieruzzi, Adio Miliozzi, Luigi Torre and José Maria Kenny</i></p> <p>10.1 Introduction 296</p> <p>10.2 Thermal Energy Storage 298</p> <p>10.3 Nanofluids for Thermal Energy Storage 313</p> <p>10.4 Nanofluids Based on Molten Salts: Enhancement of Thermal Properties 330</p> <p>10.5 Conclusions 349</p> <p>References 351</p> <p><b>11 Resistive Switching of Vertically Aligned Carbon Nanotubes for Advanced Nanoelectronics Devices 361<br /> </b><i>O.A. Ageev, Yu. F. Blinov, M.V. Il’ina, B.G. Konoplev and V.A. Smirnov</i></p> <p>11.1 Introduction 362</p> <p>11.2 Theoretical Description of Resistive Switching Mechanism of Structures Based on VACNT 363</p> <p>11.3 Techniques for Measuring the Electrical Resistivity and Young’s Modulus of VACNT Based on Scanning Probe Microscopy 377</p> <p>11.4 Experimental Studies of Resistive Switching in Structures Based on VACNT Using Scanning Tunnel Microscopy 384</p> <p>References 391</p> <p><b>12 Multi-objective Design of Nanoscale Double Gate MOSFET Devices Using Surrogate Modeling and Global Optimization 395</b><br /> <i>T. Bentrcia, F. Djeffal and E. Chebaki</i></p> <p>12.1 Introduction 396</p> <p>12.2 Downscaling Parasitic Effects 400</p> <p>12.3 Modeling Framework 405</p> <p>12.4 Simulation and Results 412</p> <p>12.5 Concluding Remarks 422</p> <p>References 422</p> <p><b>13 Graphene-based Electrochemical Biosensors: New Trends and Applications 427<br /> </b><i>Georgia-Paraskevi Nikoleli, Stephanos Karapetis, Spyridoula Bratakou, Dimitrios P. Nikolelis, Nikolaos Tzamtzis and Vasillios N. Psychoyios</i></p> <p>13.1 Introduction 428</p> <p>13.2 Scope of This Review 429</p> <p>13.3 Graphene and Sensors 430</p> <p>13.4 Graphene Nanomaterials Used in Electrochemical (Bio)sensors Fabrication 430</p> <p>13.5 Graphene-based Enzymatic Electrodes 432</p> <p>13.6 Graphene-based Electrochemical DNA Sensors 437</p> <p>13.7 Graphene-based Electrochemical Immunosensors 439</p> <p>13.8 Commercial Activities in the Field of Graphene Sensors 442</p> <p>13.9 Recent Developments in the Field of Graphene Sensors 442</p> <p>13.10 Conclusions and Future Prospects 443</p> <p>Acknowledgments 445</p> <p>References 445</p> <p><b>Part 3 Smart Nanocomposites, Fabrication, and Applications</b></p> <p><b>14 Carbon Fibers-based Silica Aerogel Nanocomposites 451<br /> </b><i>Agnieszka Ślosarczyk</i></p> <p>14.1 Introduction to Nanotechnology 451</p> <p>14.2 Chemistry of Sol–gel Process 454</p> <p>14.3 Types of Silica Aerogel Nanocomposites 462</p> <p>14.4 Carbon Fiber-based Silica Aerogel Nanocomposites 476</p> <p>14.5 Conclusions 493</p> <p>References 494</p> <p><b>15 Hydrogel–carbon Nanotubes Composites for Protection of Egg Yolk Antibodies 501<br /> </b><i>Bellingeri Romina, Alustiza Fabrisio, Picco Natalia, Motta Carlos, Grosso Maria C, Barbero Cesar, Acevedo Diego and Vivas Adriana</i></p> <p>15.1 Introduction 502</p> <p>15.2 Polymeric Hydrogels 504</p> <p>15.3 Carbon Nanotubes 507</p> <p>15.4 Polymer–CNT Composites 511</p> <p>15.5 Egg Yolk Antibodies Protection 515</p> <p>15.6 In Vitro Evaluation of Nanocomposite Performance 517</p> <p>15.7 In Vivo Evaluation of Nanocomposite Performance 518</p> <p>15.8 Concluding Remarks and Future Trends 521</p> <p>References 522</p> <p><b>16 Green Fabrication of Metal Nanoparticles 533<br /> </b><i>Anamika Mubayi, Sanjukta Chatterji and Geeta Watal</i></p> <p>16.1 Introduction 533</p> <p>16.2 Development of Herbal Medicines 535</p> <p>16.3 Green Synthesis of Nanoparticles 536</p> <p>16.4 Characterization of Phytofabricated Nanoparticles 539</p> <p>16.5 Impact of Plant-mediated Nanoparticles on Therapeutic Efficacy of Medicinal Plants 540</p> <p>16.6 Conclusions 550</p> <p>References 551</p>